US20110250593A1 - Testing lumenectomy samples for markers of non-vascular diseases - Google Patents
Testing lumenectomy samples for markers of non-vascular diseases Download PDFInfo
- Publication number
- US20110250593A1 US20110250593A1 US13/167,767 US201113167767A US2011250593A1 US 20110250593 A1 US20110250593 A1 US 20110250593A1 US 201113167767 A US201113167767 A US 201113167767A US 2011250593 A1 US2011250593 A1 US 2011250593A1
- Authority
- US
- United States
- Prior art keywords
- disease
- lumenectomy
- tissue sample
- patient
- lumenectomy material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Definitions
- This invention is related to the area of disease diagnosis and prognosis. In particular, it relates to testing for disease markers in lumenectomy samples, such as samples from a blood vessel.
- Atherosclerosis occurs naturally as a result of aging, but may also be aggravated by factors such as diet, hypertension, heredity, vascular injury, and the like. Atheromatous and other vascular deposits restrict blood flow and can cause ischemia which, in acute cases, can result in myocardial infarction. Atheromatous deposits can have widely varying properties, with some deposits being relatively soft and others being fibrous and/or calcified. In the latter case, the deposits are frequently referred to as plaque.
- Endoluminal stents are commonly used to treat obstructed or weakened body lumens, such as blood vessels and other vascular lumens. Once deployed in the blood vessel, the stent can remain in the body lumen where it will maintain the patency of the lumen and/or support the walls of the lumen which surround it.
- One factor impeding the success of stent technology in endoluminal treatments is the frequent occurrence of in-stent restenosis, characterized by proliferation and migration of smooth muscle cells within and/or adjacent to the implanted stent, causing reclosure or blockage of the body lumen.
- Atherectomy catheters intended to excise material from the blood vessel lumen generally employ a rotatable and/or axially translatable cutting blade which can be advanced into or past the occlusive material in order to cut and separate such material from the blood vessel lumen.
- side-cutting atherectomy catheters generally employ a housing having an aperture on one side, a blade which is rotated or translated by the aperture, and a balloon to urge the aperture against the material to be removed.
- Atherectomy catheters have proven very successful in treating many types of atherosclerosis and in-stent restenosis, improved atherectomy catheters and methods are continuously being pursued.
- many currently available side-cutting atherectomy catheters have difficulty in capturing occluding material in the cutting aperture.
- the cutting aperture is frequently elongated to increase the area into which the material can penetrate.
- Such elongation typically requires an equivalent lengthening of the cutter housing. Since most cutter housings are rigid, such lengthening makes it more difficult to introduce the distal end of the catheter through tortuous regions of the vasculature.
- Atherectomy catheters typically require a balloon positioned opposite the cutting window to urge the cutting window into contact with occluding material. Such balloons, however, unduly increase the size of the distal portion of the catheter. Even with the balloon, the amount of material that can be removed by conventional atherectomy catheters is limited by the size of the cutting window.
- Other disadvantages of some catheters include cutting elements with less than ideal hardness, inadequate storage space within the catheter for containing removed material, sub-optimal guide wire lumens, and/or the like.
- the available atherectomy catheters generally provide material insufficient in quantity and/or quality for testing by many histological, array, proteomic or other biochemical or molecular methods.
- Atherectomy catheters which can access small, tortuous regions of the vasculature and remove atheromatous and other occluding materials from within blood vessels and stents in a controlled fashion.
- these atherectomy catheters facilitate capturing and invagination of atheromatous materials.
- these catheters are capable of in vivo capturing and removing of continuous tissue strands of sufficient quantity and quality for testing in vitro.
- These catheters and methods for their use are adaptable for use in a variety of body lumens, including but not limited to coronary and other arteries.
- One aspect of the invention provides a method of determining the presence or likelihood of a condition of a patient.
- a lumenectomy material comprising at least one continuous tissue strand collected in vivo from an inner surface of a body lumen of a subject is tested for the presence of at least one marker of a disease selected from the group consisting of hypertension, hyperlipidemia, depression, obesity, metabolic syndrome, insulin resistance, kidney damage, and diabetes.
- the patient is identified as having or as likely to develop the disease if a marker of the disease is identified in the lumenectomy material of the subject.
- the inventors have developed methods for testing for the presence or likelihood of certain diseases. Rather than testing for certain disease makers in serum, for example, the present methods test for disease markers in lumenectomy samples, such as artherectomy samples.
- Lumens from which the test sample can be harvested include blood vessels, such as the coronary artery, the gastrointestinal tract, such as the intestine, airways, such as the bronchi and the trachea, tear ducts, mammary ducts, kidney tubules, ureters, bladders, urethras, vas deferens, epididymis, and fallopian tubes.
- Lumenectomy catheters which can be used to collect the samples of the present invention are described in U.S. application publication no. 20050177068, the disclosure of which is expressly incorporated herein. Other lumenectomy catheters which provide sufficient material for testing may also be used.
- the amount of material collected can be about 1 mg to about 2000 mg, more typically the amount of material can be about 1 mg to about 100 mg, about 100 mg to about 200 mg, about 200 mg to about 300 mg, about 300 mg to about 400 mg, about 400 mg to about 500 mg, about 500 mg to about 600 mg, about 600 mg to about 700 mg, about 700 mg to about 800 mg, or about 800 mg up to about 2000 mg.
- the material excised from the body lumen will vary in length and will depend on the catheter configuration, the type of material removed, the body lumen, and the like. However, in certain embodiments, the material will be in the form of continuous strands that have a substantially consistent depth and width of tissue cuts.
- the material is typically longer than the length of the cutting window (but it may be shorter), and typically has a length of at least about 2.0 mm, although the length may be between about 0.5 cm up to about 10 cm or longer in length.
- the planing action of the catheter provides a material tissue structure that reflects the actual in vivo tissue structure, and provides information about larger portions of the disease state of the body lumen.
- Markers which can be tested are any for which an association has been established between the marker and the disease or imminent onset of the disease. Markers can be, for example, proteins, enzymes, or RNAs. The marker can be the presence or absence of a substance or an increased or decreased level of the substance.
- the material collected from the body lumen is typically a continuous strip of tissue that may be longer than the cutting window of the lumenectomy catheter.
- This material can provide a sufficient amount of sample material of a quality and quantity that can be used for one or more of genomic screening, DNA hybridization, RNA hybridization, gene expression analysis, PCR amplification, proteomic testing, drug efficacy screening, protein marker detection, DNA marker detection, RNA marker detection, histological testing, histopathology, cytopathology, cell and tissue type analysis, biopsy, or the like.
- the material collected may be sufficient in amount and quality for testing for one or more of the presence of a DNA, an RNA, or a protein marker.
- the markers may be in the category of apoptotic markers, cell cycle proteins, transcriptional factors, proliferative markers, endothelial growth factors, adhesion molecules, cytokines, chemokines, chemokine receptors, inflammation markers, coagulation factors, fibrinolytic factors, oxidative stress related molecules, extracellular matrix molecules, interleukins, growth factors, glycoproteins, proteoglycans, cell-surface markers, serum markers, or immune factors.
- Other types of markers which are established as associated with the diseases may be used as well.
- markers which may be used include C-reactive protein, interleukin-6, and/or intracellular adhesion molecule-1 for depression; angiotensin II, aldosterone, and/or atrial natriuretic factor for hypertension; tissue factor pathway inhibitor, plasminogen activator inhibitor-1, triglycerides, and/or apolipoprotein B for hyperlipidemia; triglycerides for insulin resistance; low density lipoprotein, Remnant-like particles-cholesterol and/or triglycerides for diabetes; triglyceride-rich lipoproteins for kidney damage.
- Other markers as are known in the art and which are associated with specific diseases can be used as well, without limitation.
- Particular types of tests that can be carried out successfully on the excised lumenectomy material removed by the methods of the present invention include, but are not limited to, enzyme histochemistry, immunohistology, immunocytochemistry, immunoassays, immunofluorescent assays, immunoprecipitation assays, ELISA, flow cytometry, fluorescent activated cell sorting, radioimmunochemistry, electrophoresis, two-dimensional gel electrophoresis, Western blotting, protein sequencing, mass spectrometry, proteomic analysis, and protein microarray analysis.
- Northern blotting RNase protection assays, in situ hybridization assays, DNA microarray testing, reverse transcription polymerase chain reaction PCR (RT-PCR), Southern blotting, DNA sequencing, PCR amplification, single strand conformational polymorphism assays, single strand polymorphism (SNP) assays, and serial analysis of gene expression (SAGE) assays can be successfully carried out with the lumenectomy material compositions collected by the disclosed methods.
- RT-PCR reverse transcription polymerase chain reaction PCR
- SNP single strand polymorphism
- SAGE serial analysis of gene expression
- the material Prior to testing the harvested material, the material can optionally be placed in a preserving agent, a tissue fixative, or a preparation agent compatible with a particular test to be run.
- Agents known in the art for preserving, fixing or preparing the material for later use include, for example, saline, heparinized saline, liquid nitrogen, formalin, a membrane lysis agent, an RNA or DNA preparation agent, and the like.
- the material can be collected in a single access or can be collected in multiple translumenal accesses in the same patient. Further the material is typically at least one substantially consistent, continuous strip of material that maintains the structure of the material as it was removed from the inner surface of the lumen of the patient. Also, sample material can be collected from one, two, or more sites in the same or a different body lumen of a patient.
- the lumenectomy catheters can achieve selective plaque excision, i.e., they can specifically target diseased areas.
- samples are enriched in disease markers, relative to serum samples, in which disease markers are diluted with other substances from non-diseased tissues. Nonetheless, serum testing may be performed in conjunction with the lumenectomy evaluation, and the results used, for example, to confirm each other.
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 11/356,460, filed Feb. 17, 2006, the contents of which is hereby incorporated by reference herein.
- This invention is related to the area of disease diagnosis and prognosis. In particular, it relates to testing for disease markers in lumenectomy samples, such as samples from a blood vessel.
- Cardiovascular disease frequently arises from the accumulation of atheromatous material on the inner walls of vascular lumens, particularly arterial lumens of the coronary and other vasculature, resulting in a condition known as atherosclerosis. Atherosclerosis occurs naturally as a result of aging, but may also be aggravated by factors such as diet, hypertension, heredity, vascular injury, and the like. Atheromatous and other vascular deposits restrict blood flow and can cause ischemia which, in acute cases, can result in myocardial infarction. Atheromatous deposits can have widely varying properties, with some deposits being relatively soft and others being fibrous and/or calcified. In the latter case, the deposits are frequently referred to as plaque.
- One conventional treatment for cardiovascular disease is the use of stents. Endoluminal stents are commonly used to treat obstructed or weakened body lumens, such as blood vessels and other vascular lumens. Once deployed in the blood vessel, the stent can remain in the body lumen where it will maintain the patency of the lumen and/or support the walls of the lumen which surround it. One factor impeding the success of stent technology in endoluminal treatments is the frequent occurrence of in-stent restenosis, characterized by proliferation and migration of smooth muscle cells within and/or adjacent to the implanted stent, causing reclosure or blockage of the body lumen.
- Atherosclerosis and restenosis can be treated in a variety of ways, including drugs, bypass surgery, and a variety of catheter-based approaches which rely on intravascular debulking or removal of the atheromatous or other material occluding a blood vessel. Of particular interest to the present invention, a variety of methods for cutting or dislodging material and removing such material from the blood vessel have been proposed, generally being referred to as atherectomy procedures. Atherectomy catheters intended to excise material from the blood vessel lumen generally employ a rotatable and/or axially translatable cutting blade which can be advanced into or past the occlusive material in order to cut and separate such material from the blood vessel lumen. In particular, side-cutting atherectomy catheters generally employ a housing having an aperture on one side, a blade which is rotated or translated by the aperture, and a balloon to urge the aperture against the material to be removed.
- Although atherectomy catheters have proven very successful in treating many types of atherosclerosis and in-stent restenosis, improved atherectomy catheters and methods are continuously being pursued. For example, many currently available side-cutting atherectomy catheters have difficulty in capturing occluding material in the cutting aperture. To facilitate material capture, the cutting aperture is frequently elongated to increase the area into which the material can penetrate. Such elongation typically requires an equivalent lengthening of the cutter housing. Since most cutter housings are rigid, such lengthening makes it more difficult to introduce the distal end of the catheter through tortuous regions of the vasculature.
- Another shortcoming of many currently available atherectomy catheters is that they typically require a balloon positioned opposite the cutting window to urge the cutting window into contact with occluding material. Such balloons, however, unduly increase the size of the distal portion of the catheter. Even with the balloon, the amount of material that can be removed by conventional atherectomy catheters is limited by the size of the cutting window. Other disadvantages of some catheters include cutting elements with less than ideal hardness, inadequate storage space within the catheter for containing removed material, sub-optimal guide wire lumens, and/or the like. In addition, the available atherectomy catheters generally provide material insufficient in quantity and/or quality for testing by many histological, array, proteomic or other biochemical or molecular methods. For example, in one report a device and method available to the artisan collected less than about 50 mg of tissue. (Safian et al., Circulation 82: 305-307 (1990)). This amount of material is not typically enough to carry out more than one test, or is insufficient to successfully carry out a number of diagnostic tests available to the physician or researcher.
- Recently atherectomy catheters have been developed which can access small, tortuous regions of the vasculature and remove atheromatous and other occluding materials from within blood vessels and stents in a controlled fashion. In particular, these atherectomy catheters facilitate capturing and invagination of atheromatous materials. Particularly, these catheters are capable of in vivo capturing and removing of continuous tissue strands of sufficient quantity and quality for testing in vitro. These catheters and methods for their use are adaptable for use in a variety of body lumens, including but not limited to coronary and other arteries.
- There is a continuing need in the art to develop new methods for accurate and early assessments of disease states and incipient or imminent disease states.
- One aspect of the invention provides a method of determining the presence or likelihood of a condition of a patient. A lumenectomy material comprising at least one continuous tissue strand collected in vivo from an inner surface of a body lumen of a subject is tested for the presence of at least one marker of a disease selected from the group consisting of hypertension, hyperlipidemia, depression, obesity, metabolic syndrome, insulin resistance, kidney damage, and diabetes. The patient is identified as having or as likely to develop the disease if a marker of the disease is identified in the lumenectomy material of the subject.
- This and other embodiments which will be apparent to those of skill in the art upon reading the specification provide the art with methods for detection, diagnosis, and prognosis of diseases.
- The inventors have developed methods for testing for the presence or likelihood of certain diseases. Rather than testing for certain disease makers in serum, for example, the present methods test for disease markers in lumenectomy samples, such as artherectomy samples.
- Diseases which can be evaluated using the method of the invention include, but are not limited to, hypertension, hyperlipidemia, depression, obesity, diabetes, insulin resistance, metabolic syndrome, kidney disease, and kidney damage. Lumens from which the test sample can be harvested include blood vessels, such as the coronary artery, the gastrointestinal tract, such as the intestine, airways, such as the bronchi and the trachea, tear ducts, mammary ducts, kidney tubules, ureters, bladders, urethras, vas deferens, epididymis, and fallopian tubes.
- Lumenectomy catheters which can be used to collect the samples of the present invention are described in U.S. application publication no. 20050177068, the disclosure of which is expressly incorporated herein. Other lumenectomy catheters which provide sufficient material for testing may also be used. In certain embodiments the amount of material collected can be about 1 mg to about 2000 mg, more typically the amount of material can be about 1 mg to about 100 mg, about 100 mg to about 200 mg, about 200 mg to about 300 mg, about 300 mg to about 400 mg, about 400 mg to about 500 mg, about 500 mg to about 600 mg, about 600 mg to about 700 mg, about 700 mg to about 800 mg, or about 800 mg up to about 2000 mg.
- The material excised from the body lumen will vary in length and will depend on the catheter configuration, the type of material removed, the body lumen, and the like. However, in certain embodiments, the material will be in the form of continuous strands that have a substantially consistent depth and width of tissue cuts. The material is typically longer than the length of the cutting window (but it may be shorter), and typically has a length of at least about 2.0 mm, although the length may be between about 0.5 cm up to about 10 cm or longer in length. Advantageously, the planing action of the catheter provides a material tissue structure that reflects the actual in vivo tissue structure, and provides information about larger portions of the disease state of the body lumen.
- Markers which can be tested are any for which an association has been established between the marker and the disease or imminent onset of the disease. Markers can be, for example, proteins, enzymes, or RNAs. The marker can be the presence or absence of a substance or an increased or decreased level of the substance. The material collected from the body lumen is typically a continuous strip of tissue that may be longer than the cutting window of the lumenectomy catheter. This material can provide a sufficient amount of sample material of a quality and quantity that can be used for one or more of genomic screening, DNA hybridization, RNA hybridization, gene expression analysis, PCR amplification, proteomic testing, drug efficacy screening, protein marker detection, DNA marker detection, RNA marker detection, histological testing, histopathology, cytopathology, cell and tissue type analysis, biopsy, or the like. In addition, the material collected may be sufficient in amount and quality for testing for one or more of the presence of a DNA, an RNA, or a protein marker.
- Generally the markers may be in the category of apoptotic markers, cell cycle proteins, transcriptional factors, proliferative markers, endothelial growth factors, adhesion molecules, cytokines, chemokines, chemokine receptors, inflammation markers, coagulation factors, fibrinolytic factors, oxidative stress related molecules, extracellular matrix molecules, interleukins, growth factors, glycoproteins, proteoglycans, cell-surface markers, serum markers, or immune factors. Other types of markers which are established as associated with the diseases may be used as well.
- Specific markers which may be used include C-reactive protein, interleukin-6, and/or intracellular adhesion molecule-1 for depression; angiotensin II, aldosterone, and/or atrial natriuretic factor for hypertension; tissue factor pathway inhibitor, plasminogen activator inhibitor-1, triglycerides, and/or apolipoprotein B for hyperlipidemia; triglycerides for insulin resistance; low density lipoprotein, Remnant-like particles-cholesterol and/or triglycerides for diabetes; triglyceride-rich lipoproteins for kidney damage. Other markers as are known in the art and which are associated with specific diseases can be used as well, without limitation.
- Particular types of tests that can be carried out successfully on the excised lumenectomy material removed by the methods of the present invention include, but are not limited to, enzyme histochemistry, immunohistology, immunocytochemistry, immunoassays, immunofluorescent assays, immunoprecipitation assays, ELISA, flow cytometry, fluorescent activated cell sorting, radioimmunochemistry, electrophoresis, two-dimensional gel electrophoresis, Western blotting, protein sequencing, mass spectrometry, proteomic analysis, and protein microarray analysis. Further, Northern blotting, RNase protection assays, in situ hybridization assays, DNA microarray testing, reverse transcription polymerase chain reaction PCR (RT-PCR), Southern blotting, DNA sequencing, PCR amplification, single strand conformational polymorphism assays, single strand polymorphism (SNP) assays, and serial analysis of gene expression (SAGE) assays can be successfully carried out with the lumenectomy material compositions collected by the disclosed methods.
- Prior to testing the harvested material, the material can optionally be placed in a preserving agent, a tissue fixative, or a preparation agent compatible with a particular test to be run. Agents known in the art for preserving, fixing or preparing the material for later use include, for example, saline, heparinized saline, liquid nitrogen, formalin, a membrane lysis agent, an RNA or DNA preparation agent, and the like. The material can be collected in a single access or can be collected in multiple translumenal accesses in the same patient. Further the material is typically at least one substantially consistent, continuous strip of material that maintains the structure of the material as it was removed from the inner surface of the lumen of the patient. Also, sample material can be collected from one, two, or more sites in the same or a different body lumen of a patient.
- The lumenectomy catheters can achieve selective plaque excision, i.e., they can specifically target diseased areas. Thus the samples are enriched in disease markers, relative to serum samples, in which disease markers are diluted with other substances from non-diseased tissues. Nonetheless, serum testing may be performed in conjunction with the lumenectomy evaluation, and the results used, for example, to confirm each other.
- The above disclosure generally describes the present invention. All references disclosed herein are expressly incorporated by reference. A more complete understanding can be obtained by reference to the following specific examples which are provided herein for purposes of illustration only, and are not intended to limit the scope of the invention.
- The disclosure of each reference cited is expressly incorporated herein.
- Yu H. et al., Hypertension 2000; 35:135
- Raij, L., Hypertension, 2001; 37:767
- Tomiyama, H., et al., Hypertension, 2005; 45:997
- Guo, X., et al., Hypertension, 2005; 45:799
- Sarnak, M. et al., Hypertension, 2003; 42:1050
- Cassidy, A., et al., Circulation, 2005; 111:1877-1882
- Empana, J. P., et al., Circulation, 2005; 111:2299-2305
- Bolterman, R. et al., Hypertension, 2005, doi: 10/1161/01.HYP.0000174602.59935.D5
- Preston, R., et al., Hypertension, 2003; 41:211
- Zitoun, D., et al., Arteriosclerosis, Thrombosis, and Vascular Biology. 1996; 16:77-81
- Sijbrands, E., et al., Arteriosclerosis, Thrombosis, and Vascular Biology. 1999; 19:2722
- Mar, R., et al., Circulation Research. 2004; 94:993
- Twickler, T. B., et al., Circulation. 2004; 109:1918-1925
Claims (20)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/167,767 US20110250593A1 (en) | 2006-02-17 | 2011-06-24 | Testing lumenectomy samples for markers of non-vascular diseases |
US13/362,249 US20120129163A1 (en) | 2006-02-17 | 2012-01-31 | Testing lumenectomy samples for markers of non-vascular diseases |
US13/598,154 US20120322688A1 (en) | 2006-02-17 | 2012-08-29 | Testing lumenectomy samples for markers of non-vascular diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/356,460 US7989207B2 (en) | 2006-02-17 | 2006-02-17 | Testing lumenectomy samples for markers of non-vascular diseases |
US13/167,767 US20110250593A1 (en) | 2006-02-17 | 2011-06-24 | Testing lumenectomy samples for markers of non-vascular diseases |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/356,460 Continuation US7989207B2 (en) | 2006-02-17 | 2006-02-17 | Testing lumenectomy samples for markers of non-vascular diseases |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/362,249 Continuation US20120129163A1 (en) | 2006-02-17 | 2012-01-31 | Testing lumenectomy samples for markers of non-vascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110250593A1 true US20110250593A1 (en) | 2011-10-13 |
Family
ID=38235243
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/356,460 Active 2027-12-08 US7989207B2 (en) | 2006-02-17 | 2006-02-17 | Testing lumenectomy samples for markers of non-vascular diseases |
US13/167,767 Abandoned US20110250593A1 (en) | 2006-02-17 | 2011-06-24 | Testing lumenectomy samples for markers of non-vascular diseases |
US13/362,249 Abandoned US20120129163A1 (en) | 2006-02-17 | 2012-01-31 | Testing lumenectomy samples for markers of non-vascular diseases |
US13/598,154 Abandoned US20120322688A1 (en) | 2006-02-17 | 2012-08-29 | Testing lumenectomy samples for markers of non-vascular diseases |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/356,460 Active 2027-12-08 US7989207B2 (en) | 2006-02-17 | 2006-02-17 | Testing lumenectomy samples for markers of non-vascular diseases |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/362,249 Abandoned US20120129163A1 (en) | 2006-02-17 | 2012-01-31 | Testing lumenectomy samples for markers of non-vascular diseases |
US13/598,154 Abandoned US20120322688A1 (en) | 2006-02-17 | 2012-08-29 | Testing lumenectomy samples for markers of non-vascular diseases |
Country Status (3)
Country | Link |
---|---|
US (4) | US7989207B2 (en) |
EP (1) | EP1994414A2 (en) |
WO (1) | WO2007098085A2 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794413B2 (en) * | 2005-04-19 | 2010-09-14 | Ev3, Inc. | Libraries and data structures of materials removed by debulking catheters |
US7989207B2 (en) * | 2006-02-17 | 2011-08-02 | Tyco Healthcare Group Lp | Testing lumenectomy samples for markers of non-vascular diseases |
US8548571B2 (en) | 2009-12-08 | 2013-10-01 | Avinger, Inc. | Devices and methods for predicting and preventing restenosis |
US20100125253A1 (en) * | 2008-11-17 | 2010-05-20 | Avinger | Dual-tip Catheter System for Boring through Blocked Vascular Passages |
US8062316B2 (en) | 2008-04-23 | 2011-11-22 | Avinger, Inc. | Catheter system and method for boring through blocked vascular passages |
US9125562B2 (en) | 2009-07-01 | 2015-09-08 | Avinger, Inc. | Catheter-based off-axis optical coherence tomography imaging system |
WO2010129075A1 (en) | 2009-04-28 | 2010-11-11 | Avinger, Inc. | Guidewire support catheter |
CA2763324C (en) | 2009-05-28 | 2018-10-23 | Avinger, Inc. | Optical coherence tomography for biological imaging |
EP2448502B1 (en) | 2009-07-01 | 2022-04-06 | Avinger, Inc. | Atherectomy catheter with laterally-displaceable tip |
JP2013531542A (en) | 2010-07-01 | 2013-08-08 | アビンガー・インコーポレイテッド | An atherectomy catheter having a longitudinally movable drive shaft |
WO2014039096A1 (en) | 2012-09-06 | 2014-03-13 | Avinger, Inc. | Re-entry stylet for catheter |
US11382653B2 (en) | 2010-07-01 | 2022-07-12 | Avinger, Inc. | Atherectomy catheter |
WO2014039099A1 (en) | 2012-09-06 | 2014-03-13 | Avinger, Inc. | Balloon atherectomy catheters with imaging |
WO2012145133A2 (en) | 2011-03-28 | 2012-10-26 | Avinger, Inc. | Occlusion-crossing devices, imaging, and atherectomy devices |
US9949754B2 (en) | 2011-03-28 | 2018-04-24 | Avinger, Inc. | Occlusion-crossing devices |
WO2013059363A1 (en) | 2011-10-17 | 2013-04-25 | Avinger, Inc. | Atherectomy catheters and non-contact actuation mechanism for catheters |
US9345406B2 (en) | 2011-11-11 | 2016-05-24 | Avinger, Inc. | Occlusion-crossing devices, atherectomy devices, and imaging |
EP2849636B1 (en) | 2012-05-14 | 2020-04-22 | Avinger, Inc. | Optical coherence tomography with graded index fiber for biological imaging |
EP2849661B1 (en) | 2012-05-14 | 2020-12-09 | Avinger, Inc. | Atherectomy catheters with imaging |
EP2849660B1 (en) | 2012-05-14 | 2021-08-25 | Avinger, Inc. | Atherectomy catheter drive assemblies |
US11284916B2 (en) | 2012-09-06 | 2022-03-29 | Avinger, Inc. | Atherectomy catheters and occlusion crossing devices |
US9498247B2 (en) | 2014-02-06 | 2016-11-22 | Avinger, Inc. | Atherectomy catheters and occlusion crossing devices |
US10932670B2 (en) | 2013-03-15 | 2021-03-02 | Avinger, Inc. | Optical pressure sensor assembly |
US11096717B2 (en) | 2013-03-15 | 2021-08-24 | Avinger, Inc. | Tissue collection device for catheter |
WO2014143064A1 (en) | 2013-03-15 | 2014-09-18 | Avinger, Inc. | Chronic total occlusion crossing devices with imaging |
EP3019096B1 (en) | 2013-07-08 | 2023-07-05 | Avinger, Inc. | System for identification of elastic lamina to guide interventional therapy |
CN106102608B (en) | 2014-02-06 | 2020-03-24 | 阿维格公司 | Atherectomy catheters and occlusion crossing devices |
EP3166512B1 (en) | 2014-07-08 | 2020-08-19 | Avinger, Inc. | High speed chronic total occlusion crossing devices |
CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
JP6841609B2 (en) | 2015-07-10 | 2021-03-10 | 3スキャン インコーポレイテッド | Spatial multiplexing of histological staining |
US10568520B2 (en) | 2015-07-13 | 2020-02-25 | Avinger, Inc. | Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters |
EP3407777B1 (en) | 2016-01-25 | 2020-12-30 | Avinger, Inc. | Oct imaging catheter with lag correction |
CN108882948A (en) | 2016-04-01 | 2018-11-23 | 阿维格公司 | Rotary-cut art conduit with zigzag cutter |
WO2017210466A1 (en) | 2016-06-03 | 2017-12-07 | Avinger, Inc. | Catheter device with detachable distal end |
CN109414273B (en) | 2016-06-30 | 2023-02-17 | 阿维格公司 | Atherectomy catheter with shapeable distal tip |
EP4044942A4 (en) | 2019-10-18 | 2023-11-15 | Avinger, Inc. | Occlusion-crossing devices |
US11471183B1 (en) | 2021-02-18 | 2022-10-18 | Boston Scientific Scimed, Inc. | Thrombectomy methods |
US11504151B2 (en) | 2021-02-18 | 2022-11-22 | Boston Scientific Scimed, Inc. | Thrombectomy apparatuses |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5406959A (en) * | 1992-06-22 | 1995-04-18 | Mann; David | Method and apparatus for obtaining an arterial biopsy and for diagnosting diseases of the vascular system |
US5571130A (en) * | 1994-10-04 | 1996-11-05 | Advanced Cardiovascular Systems, Inc. | Atherectomy and prostectomy system |
US5843000A (en) * | 1996-05-07 | 1998-12-01 | The General Hospital Corporation | Optical biopsy forceps and method of diagnosing tissue |
US20030219813A1 (en) * | 2002-04-05 | 2003-11-27 | Millennium Pharmaceuticals, Inc. | Identification of a family of secreted proteins in vascular endothelium |
US7989207B2 (en) * | 2006-02-17 | 2011-08-02 | Tyco Healthcare Group Lp | Testing lumenectomy samples for markers of non-vascular diseases |
Family Cites Families (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2178700A (en) | 1938-01-24 | 1939-11-07 | Arthur J Penick | Tubing head |
ES152231Y (en) | 1969-10-02 | 1970-07-01 | Ballestero Sierra | A PERFECTED TROCAR. |
US3815604A (en) | 1972-06-19 | 1974-06-11 | Malley C O | Apparatus for intraocular surgery |
US3837345A (en) | 1973-08-31 | 1974-09-24 | A Matar | Venous valve snipper |
US3995619A (en) | 1975-10-14 | 1976-12-07 | Glatzer Stephen G | Combination subcutaneous suture remover, biopsy sampler and syringe |
US4210146A (en) * | 1978-06-01 | 1980-07-01 | Anton Banko | Surgical instrument with flexible blade |
US5024651A (en) * | 1984-05-14 | 1991-06-18 | Surgical Systems & Instruments, Inc. | Atherectomy system with a sleeve |
US4979951A (en) | 1984-05-30 | 1990-12-25 | Simpson John B | Atherectomy device and method |
US4926858A (en) * | 1984-05-30 | 1990-05-22 | Devices For Vascular Intervention, Inc. | Atherectomy device for severe occlusions |
US4781186A (en) | 1984-05-30 | 1988-11-01 | Devices For Vascular Intervention, Inc. | Atherectomy device having a flexible housing |
USRE33258E (en) * | 1984-07-23 | 1990-07-10 | Surgical Dynamics Inc. | Irrigating, cutting and aspirating system for percutaneous surgery |
US4696298A (en) | 1985-11-19 | 1987-09-29 | Storz Instrument Company | Vitrectomy cutting mechanism |
US4669489A (en) * | 1985-12-02 | 1987-06-02 | Deere & Company | Straw chopper mounting for a combine |
US4669469A (en) | 1986-02-28 | 1987-06-02 | Devices For Vascular Intervention | Single lumen atherectomy catheter device |
US4771774A (en) | 1986-02-28 | 1988-09-20 | Devices For Vascular Intervention, Inc. | Motor drive unit |
US4761186A (en) * | 1986-08-18 | 1988-08-02 | General Foods Corporation | Method of purifying starches and products produced therefrom |
US4817613A (en) * | 1987-07-13 | 1989-04-04 | Devices For Vascular Intervention, Inc. | Guiding catheter |
US4819635A (en) * | 1987-09-18 | 1989-04-11 | Henry Shapiro | Tubular microsurgery cutting apparatus |
US5047040A (en) | 1987-11-05 | 1991-09-10 | Devices For Vascular Intervention, Inc. | Atherectomy device and method |
US5053044A (en) | 1988-01-11 | 1991-10-01 | Devices For Vascular Intervention, Inc. | Catheter and method for making intravascular incisions |
US4850957A (en) * | 1988-01-11 | 1989-07-25 | American Biomed, Inc. | Atherectomy catheter |
US4986804A (en) * | 1988-04-15 | 1991-01-22 | Katana Corporation | Method for forming angular seals in side-gussetted bags |
US5071425A (en) | 1988-09-12 | 1991-12-10 | Devices For Vascular Intervention, Inc. | Atherectomy catheter and method of forming the same |
GB8829182D0 (en) * | 1988-12-14 | 1989-01-25 | Univ Birmingham | Surgical instrument |
US4966604A (en) | 1989-01-23 | 1990-10-30 | Interventional Technologies Inc. | Expandable atherectomy cutter with flexibly bowed blades |
US4986807A (en) * | 1989-01-23 | 1991-01-22 | Interventional Technologies, Inc. | Atherectomy cutter with radially projecting blade |
US5431673A (en) * | 1989-02-17 | 1995-07-11 | American Biomed, Inc. | Distal atherectomy catheter |
US4994067A (en) * | 1989-02-17 | 1991-02-19 | American Biomed, Inc. | Distal atherectomy catheter |
US5087265A (en) * | 1989-02-17 | 1992-02-11 | American Biomed, Inc. | Distal atherectomy catheter |
US5226910A (en) * | 1989-07-05 | 1993-07-13 | Kabushiki Kaisha Topcon | Surgical cutter |
US5269793A (en) | 1989-07-20 | 1993-12-14 | Devices For Vascular Intervention, Inc. | Guide wire systems for intravascular catheters |
US5282484A (en) * | 1989-08-18 | 1994-02-01 | Endovascular Instruments, Inc. | Method for performing a partial atherectomy |
US5226909A (en) * | 1989-09-12 | 1993-07-13 | Devices For Vascular Intervention, Inc. | Atherectomy device having helical blade and blade guide |
US5505210A (en) * | 1989-11-06 | 1996-04-09 | Mectra Labs, Inc. | Lavage with tissue cutting cannula |
US5916210A (en) * | 1990-01-26 | 1999-06-29 | Intraluminal Therapeutics, Inc. | Catheter for laser treatment of atherosclerotic plaque and other tissue abnormalities |
US5084010A (en) * | 1990-02-20 | 1992-01-28 | Devices For Vascular Intervention, Inc. | System and method for catheter construction |
US5092873A (en) * | 1990-02-28 | 1992-03-03 | Devices For Vascular Intervention, Inc. | Balloon configuration for atherectomy catheter |
US5222966A (en) | 1990-02-28 | 1993-06-29 | Devices For Vascular Intervention, Inc. | Balloon connection and inflation lumen for atherectomy catheter |
US5154724A (en) | 1990-05-14 | 1992-10-13 | Andrews Winston A | Atherectomy catheter |
US5100424A (en) * | 1990-05-21 | 1992-03-31 | Cardiovascular Imaging Systems, Inc. | Intravascular catheter having combined imaging abrasion head |
US5674232A (en) | 1990-06-05 | 1997-10-07 | Halliburton; Alexander George | Catheter and method of use thereof |
US5181920A (en) * | 1990-06-08 | 1993-01-26 | Devices For Vascular Intervention, Inc. | Atherectomy device with angioplasty balloon and method |
US5250065A (en) | 1990-09-11 | 1993-10-05 | Mectra Labs, Inc. | Disposable lavage tip assembly |
US5242460A (en) | 1990-10-25 | 1993-09-07 | Devices For Vascular Intervention, Inc. | Atherectomy catheter having axially-disposed cutting edge |
US6134003A (en) | 1991-04-29 | 2000-10-17 | Massachusetts Institute Of Technology | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
WO1992019930A1 (en) | 1991-04-29 | 1992-11-12 | Massachusetts Institute Of Technology | Method and apparatus for optical imaging and measurement |
US5217474A (en) * | 1991-07-15 | 1993-06-08 | Zacca Nadim M | Expandable tip atherectomy method and apparatus |
DE4126968A1 (en) * | 1991-08-14 | 1993-02-18 | Detlev Prof Dr Med Ganten | Transgenic rats that contain at least one human gene in their genome that is involved in blood pressure regulation |
US5285795A (en) * | 1991-09-12 | 1994-02-15 | Surgical Dynamics, Inc. | Percutaneous discectomy system having a bendable discectomy probe and a steerable cannula |
US5344489A (en) * | 1991-11-15 | 1994-09-06 | Manfred R. Kuehnle | Synthetic, monodispersed color pigments for the coloration of media such as printing inks, and method and apparatus for making same |
US5224949A (en) * | 1992-01-13 | 1993-07-06 | Interventional Technologies, Inc. | Camming device |
US5250059A (en) | 1992-01-22 | 1993-10-05 | Devices For Vascular Intervention, Inc. | Atherectomy catheter having flexible nose cone |
US5318032A (en) | 1992-02-05 | 1994-06-07 | Devices For Vascular Intervention | Guiding catheter having soft tip |
US5224488A (en) * | 1992-08-31 | 1993-07-06 | Neuffer Francis H | Biopsy needle with extendable cutting means |
US5318092A (en) * | 1992-09-10 | 1994-06-07 | Andrews Robert S L | Method for controlling the collapsibility of foundry molds and cores |
US5383460A (en) | 1992-10-05 | 1995-01-24 | Cardiovascular Imaging Systems, Inc. | Method and apparatus for ultrasound imaging and atherectomy |
US5643297A (en) * | 1992-11-09 | 1997-07-01 | Endovascular Instruments, Inc. | Intra-artery obstruction clearing apparatus and methods |
US5571122A (en) | 1992-11-09 | 1996-11-05 | Endovascular Instruments, Inc. | Unitary removal of plaque |
US5372602A (en) * | 1992-11-30 | 1994-12-13 | Device For Vascular Intervention, Inc. | Method of removing plaque using catheter cutter with torque control |
US5584842A (en) | 1992-12-02 | 1996-12-17 | Intramed Laboratories, Inc. | Valvulotome and method of using |
US5620447A (en) * | 1993-01-29 | 1997-04-15 | Smith & Nephew Dyonics Inc. | Surgical instrument |
US5318528A (en) | 1993-04-13 | 1994-06-07 | Advanced Surgical Inc. | Steerable surgical devices |
US5429136A (en) * | 1993-04-21 | 1995-07-04 | Devices For Vascular Intervention, Inc. | Imaging atherectomy apparatus |
US5514115A (en) * | 1993-07-07 | 1996-05-07 | Device For Vascular Intervention, Inc. | Flexible housing for intracorporeal use |
US5527325A (en) * | 1993-07-09 | 1996-06-18 | Device For Vascular Intervention, Inc. | Atherectomy catheter and method |
US5419774A (en) * | 1993-07-13 | 1995-05-30 | Scimed Life Systems, Inc. | Thrombus extraction device |
US5395313A (en) * | 1993-08-13 | 1995-03-07 | Naves; Neil H. | Reciprocating arthroscopic shaver |
US5441510A (en) * | 1993-09-01 | 1995-08-15 | Technology Development Center | Bi-axial cutter apparatus for catheter |
US5507760A (en) * | 1993-11-09 | 1996-04-16 | Devices For Vascular Intervention, Inc. | Cutter device |
AU1399995A (en) | 1993-12-09 | 1995-06-27 | Devices For Vascular Intervention, Inc. | Composite drive shaft |
FR2715296B1 (en) * | 1994-01-24 | 1996-04-12 | Oreal | Keratin fiber oxidation dyeing composition comprising a paraphenylenediamine, a metalphenylenediamine and a para-aminophenol or a meta-aminophenol, and dyeing process using such a composition. |
US5501969A (en) * | 1994-03-08 | 1996-03-26 | Human Genome Sciences, Inc. | Human osteoclast-derived cathepsin |
US5624457A (en) * | 1994-04-07 | 1997-04-29 | Devices For Vascular Intervention | Directional atherectomy device with flexible housing |
US5507795A (en) * | 1994-04-29 | 1996-04-16 | Devices For Vascular Intervention, Inc. | Catheter with perfusion system |
US5491524A (en) * | 1994-10-05 | 1996-02-13 | Carl Zeiss, Inc. | Optical coherence tomography corneal mapping apparatus |
US5549601A (en) * | 1994-10-11 | 1996-08-27 | Devices For Vascular Intervention, Inc. | Delivery of intracorporeal probes |
US5643296A (en) * | 1994-12-16 | 1997-07-01 | Devices For Vasclar Intervention | Intravascular catheter with guiding structure |
US5836957A (en) | 1994-12-22 | 1998-11-17 | Devices For Vascular Intervention, Inc. | Large volume atherectomy device |
US5632754A (en) * | 1994-12-23 | 1997-05-27 | Devices For Vascular Intervention | Universal catheter with interchangeable work element |
US6027450A (en) * | 1994-12-30 | 2000-02-22 | Devices For Vascular Intervention | Treating a totally or near totally occluded lumen |
US5700687A (en) | 1995-01-30 | 1997-12-23 | Bedminster Bioconversion Corporation | Odor control system |
US6283983B1 (en) * | 1995-10-13 | 2001-09-04 | Transvascular, Inc. | Percutaneous in-situ coronary bypass method and apparatus |
US6283951B1 (en) * | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
IL151563A0 (en) * | 1995-10-13 | 2003-04-10 | Transvascular Inc | A longitudinal compression apparatus for compressing tissue |
US6302875B1 (en) * | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
US6375615B1 (en) * | 1995-10-13 | 2002-04-23 | Transvascular, Inc. | Tissue penetrating catheters having integral imaging transducers and their methods of use |
US5830222A (en) | 1995-10-13 | 1998-11-03 | Transvascular, Inc. | Device, system and method for intersititial transvascular intervention |
US5989281A (en) | 1995-11-07 | 1999-11-23 | Embol-X, Inc. | Cannula with associated filter and methods of use during cardiac surgery |
US5868685A (en) * | 1995-11-14 | 1999-02-09 | Devices For Vascular Intervention | Articulated guidewire |
US5733296A (en) * | 1996-02-06 | 1998-03-31 | Devices For Vascular Intervention | Composite atherectomy cutter |
US5695506A (en) | 1996-02-06 | 1997-12-09 | Devices For Vascular Intervention | Catheter device with a flexible housing |
US5709698A (en) * | 1996-02-26 | 1998-01-20 | Linvatec Corporation | Irrigating/aspirating shaver blade assembly |
US6036707A (en) * | 1996-03-07 | 2000-03-14 | Devices For Vascular Intervention | Catheter device having a selectively flexible housing |
US5819738A (en) * | 1996-07-03 | 1998-10-13 | Symbiosis Corporation | Jaw assembly having progressively larger teeth and endoscopic biopsy forceps instrument incorporating same |
US5968064A (en) | 1997-02-28 | 1999-10-19 | Lumend, Inc. | Catheter system for treating a vascular occlusion |
US6010449A (en) * | 1997-02-28 | 2000-01-04 | Lumend, Inc. | Intravascular catheter system for treating a vascular occlusion |
US6217549B1 (en) * | 1997-02-28 | 2001-04-17 | Lumend, Inc. | Methods and apparatus for treating vascular occlusions |
US6120516A (en) | 1997-02-28 | 2000-09-19 | Lumend, Inc. | Method for treating vascular occlusion |
US5741270A (en) * | 1997-02-28 | 1998-04-21 | Lumend, Inc. | Manual actuator for a catheter system for treating a vascular occlusion |
US5843103A (en) | 1997-03-06 | 1998-12-01 | Scimed Life Systems, Inc. | Shaped wire rotational atherectomy device |
KR100546223B1 (en) | 1997-04-30 | 2006-01-26 | 마루하 주식회사 | Method for detecting or predicting ischemic diseases |
US5911734A (en) * | 1997-05-08 | 1999-06-15 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US5954745A (en) | 1997-05-16 | 1999-09-21 | Gertler; Jonathan | Catheter-filter set having a compliant seal |
US6048349A (en) * | 1997-07-09 | 2000-04-11 | Intraluminal Therapeutics, Inc. | Systems and methods for guiding a medical instrument through a body |
US6013072A (en) * | 1997-07-09 | 2000-01-11 | Intraluminal Therapeutics, Inc. | Systems and methods for steering a catheter through body tissue |
US5951482A (en) | 1997-10-03 | 1999-09-14 | Intraluminal Therapeutics, Inc. | Assemblies and methods for advancing a guide wire through body tissue |
US6193676B1 (en) * | 1997-10-03 | 2001-02-27 | Intraluminal Therapeutics, Inc. | Guide wire assembly |
US6183432B1 (en) * | 1997-11-13 | 2001-02-06 | Lumend, Inc. | Guidewire and catheter with rotating and reciprocating symmetrical or asymmetrical distal tip |
US5938671A (en) | 1997-11-14 | 1999-08-17 | Reflow, Inc. | Recanalization apparatus and devices for use therein and method |
US6330884B1 (en) * | 1997-11-14 | 2001-12-18 | Transvascular, Inc. | Deformable scaffolding multicellular stent |
US6027514A (en) * | 1997-12-17 | 2000-02-22 | Fox Hollow Technologies, Inc. | Apparatus and method for removing occluding material from body lumens |
US6217527B1 (en) * | 1998-09-30 | 2001-04-17 | Lumend, Inc. | Methods and apparatus for crossing vascular occlusions |
US6231546B1 (en) * | 1998-01-13 | 2001-05-15 | Lumend, Inc. | Methods and apparatus for crossing total occlusions in blood vessels |
US6081738A (en) * | 1998-01-15 | 2000-06-27 | Lumend, Inc. | Method and apparatus for the guided bypass of coronary occlusions |
AU1927399A (en) * | 1998-01-16 | 1999-08-02 | Lumend, Inc. | Catheter apparatus for treating arterial occlusions |
US6398798B2 (en) * | 1998-02-28 | 2002-06-04 | Lumend, Inc. | Catheter system for treating a vascular occlusion |
US6106515A (en) | 1998-08-13 | 2000-08-22 | Intraluminal Therapeutics, Inc. | Expandable laser catheter |
US6241744B1 (en) * | 1998-08-14 | 2001-06-05 | Fox Hollow Technologies, Inc. | Apparatus for deploying a guidewire across a complex lesion |
US6022362A (en) | 1998-09-03 | 2000-02-08 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
US6228076B1 (en) * | 1999-01-09 | 2001-05-08 | Intraluminal Therapeutics, Inc. | System and method for controlling tissue ablation |
US6191862B1 (en) | 1999-01-20 | 2001-02-20 | Lightlab Imaging, Llc | Methods and apparatus for high speed longitudinal scanning in imaging systems |
DE69908546T2 (en) * | 1999-03-25 | 2004-04-29 | Synthon B.V. | Imidazopyridine derivatives and process for their preparation |
US6126649A (en) | 1999-06-10 | 2000-10-03 | Transvascular, Inc. | Steerable catheter with external guidewire as catheter tip deflector |
US6445939B1 (en) * | 1999-08-09 | 2002-09-03 | Lightlab Imaging, Llc | Ultra-small optical probes, imaging optics, and methods for using same |
US6231549B1 (en) * | 1999-08-17 | 2001-05-15 | Sherwood Services, Ag | Shim device for enteral feeding system |
US20030120295A1 (en) * | 2000-12-20 | 2003-06-26 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US6447525B2 (en) * | 1999-08-19 | 2002-09-10 | Fox Hollow Technologies, Inc. | Apparatus and methods for removing material from a body lumen |
US6638233B2 (en) * | 1999-08-19 | 2003-10-28 | Fox Hollow Technologies, Inc. | Apparatus and methods for material capture and removal |
US7887556B2 (en) * | 2000-12-20 | 2011-02-15 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US20030125757A1 (en) * | 2000-12-20 | 2003-07-03 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US7708749B2 (en) * | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US6299622B1 (en) * | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
US8328829B2 (en) * | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
US6191662B1 (en) * | 1999-11-30 | 2001-02-20 | Intel Corporation | Self-start circuits for low-power clock oscillators |
US6394976B1 (en) * | 2000-01-31 | 2002-05-28 | Intraluminal Therapeutics, Inc. | Catheter for controlling the advancement of a guide wire |
EP2363152A1 (en) | 2000-09-06 | 2011-09-07 | Johns Hopkins University | Cardiac arrhythmia treatment methods |
US7004173B2 (en) * | 2000-12-05 | 2006-02-28 | Lumend, Inc. | Catheter system for vascular re-entry from a sub-intimal space |
WO2002048715A2 (en) * | 2000-12-14 | 2002-06-20 | The Brigham And Women's Hospital, Inc. | Inflammatory markers for detection and prevention of diabetes mellitus |
US20060032508A1 (en) * | 2000-12-20 | 2006-02-16 | Fox Hollow Technologies, Inc. | Method of evaluating a treatment for vascular disease |
US7927784B2 (en) * | 2000-12-20 | 2011-04-19 | Ev3 | Vascular lumen debulking catheters and methods |
US20050222519A1 (en) * | 2000-12-20 | 2005-10-06 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US20040167554A1 (en) | 2000-12-20 | 2004-08-26 | Fox Hollow Technologies, Inc. | Methods and devices for reentering a true lumen from a subintimal space |
US20100121360A9 (en) * | 2000-12-20 | 2010-05-13 | Fox Hollow Technologies, Inc | Testing a patient population having a cardiovascular condition for drug efficacy |
US20060235366A1 (en) * | 2000-12-20 | 2006-10-19 | Fox Hollow Technologies, Inc. | Method of evaluating a treatment for vascular disease |
US20050154407A1 (en) * | 2000-12-20 | 2005-07-14 | Fox Hollow Technologies, Inc. | Method of evaluating drug efficacy for treating atherosclerosis |
US7699790B2 (en) * | 2000-12-20 | 2010-04-20 | Ev3, Inc. | Debulking catheters and methods |
ATE499054T1 (en) * | 2000-12-20 | 2011-03-15 | Fox Hollow Technologies Inc | REDUCTION CATHETER |
US6428552B1 (en) * | 2001-01-22 | 2002-08-06 | Lumend, Inc. | Method and apparatus for crossing intravascular occlusions |
US7156859B2 (en) * | 2001-07-23 | 2007-01-02 | Fos Holding S.A. | Device for separating the epithelium layer from the surface of the cornea of an eye |
CA2457775A1 (en) | 2001-08-20 | 2003-02-27 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
US20070077614A1 (en) | 2003-04-01 | 2007-04-05 | Wolfert Robert L | Uses of lp-pla2 in combination to assess coronary risk |
US9171129B2 (en) | 2004-02-10 | 2015-10-27 | Todd J. Cohen | System and method for storing, accessing, and displaying specialized patient information and other medical information |
US7794413B2 (en) * | 2005-04-19 | 2010-09-14 | Ev3, Inc. | Libraries and data structures of materials removed by debulking catheters |
US20070038173A1 (en) * | 2005-07-27 | 2007-02-15 | Fox Hollow Technologies, Inc. | Methods affecting markers in patients having vascular disease |
CN101326439A (en) * | 2005-10-11 | 2008-12-17 | 特提斯生物科学公司 | Diabetes-associated markers and methods of use thereof |
US7606622B2 (en) * | 2006-01-24 | 2009-10-20 | Cardiac Pacemakers, Inc. | Method and device for detecting and treating depression |
-
2006
- 2006-02-17 US US11/356,460 patent/US7989207B2/en active Active
-
2007
- 2007-02-16 WO PCT/US2007/004246 patent/WO2007098085A2/en active Application Filing
- 2007-02-16 EP EP07751035A patent/EP1994414A2/en not_active Ceased
-
2011
- 2011-06-24 US US13/167,767 patent/US20110250593A1/en not_active Abandoned
-
2012
- 2012-01-31 US US13/362,249 patent/US20120129163A1/en not_active Abandoned
- 2012-08-29 US US13/598,154 patent/US20120322688A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5406959A (en) * | 1992-06-22 | 1995-04-18 | Mann; David | Method and apparatus for obtaining an arterial biopsy and for diagnosting diseases of the vascular system |
US5571130A (en) * | 1994-10-04 | 1996-11-05 | Advanced Cardiovascular Systems, Inc. | Atherectomy and prostectomy system |
US5843000A (en) * | 1996-05-07 | 1998-12-01 | The General Hospital Corporation | Optical biopsy forceps and method of diagnosing tissue |
US20030219813A1 (en) * | 2002-04-05 | 2003-11-27 | Millennium Pharmaceuticals, Inc. | Identification of a family of secreted proteins in vascular endothelium |
US7989207B2 (en) * | 2006-02-17 | 2011-08-02 | Tyco Healthcare Group Lp | Testing lumenectomy samples for markers of non-vascular diseases |
Also Published As
Publication number | Publication date |
---|---|
US20070196926A1 (en) | 2007-08-23 |
US20120322688A1 (en) | 2012-12-20 |
US7989207B2 (en) | 2011-08-02 |
WO2007098085A2 (en) | 2007-08-30 |
EP1994414A2 (en) | 2008-11-26 |
WO2007098085A3 (en) | 2008-03-20 |
US20120129163A1 (en) | 2012-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7989207B2 (en) | Testing lumenectomy samples for markers of non-vascular diseases | |
US20060032508A1 (en) | Method of evaluating a treatment for vascular disease | |
US20120179178A1 (en) | Method of evaluating a treatment for vascular disease | |
US20050154407A1 (en) | Method of evaluating drug efficacy for treating atherosclerosis | |
US7927784B2 (en) | Vascular lumen debulking catheters and methods | |
US20070078469A1 (en) | Testing a patient population having a cardiovascular condition for drug efficacy | |
US7794413B2 (en) | Libraries and data structures of materials removed by debulking catheters | |
US7699790B2 (en) | Debulking catheters and methods | |
US20070038173A1 (en) | Methods affecting markers in patients having vascular disease | |
US20050222519A1 (en) | Debulking catheters and methods | |
US5599298A (en) | Bodily sample collection balloon catheter method | |
EP0746226A1 (en) | Bodily sample collection | |
Class et al. | Patent application title: TESTING LUMENECTOMY SAMPLES FOR MARKERS OF NON-VASCULAR DISEASES Inventors: Angela Soito (Oakland, CA, US) Angela Soito (Oakland, CA, US) John B. Simpson (Woodside, CA, US) Assignees: Tyco Healthcare Group LP | |
US20130012411A1 (en) | Testing a patient population having a cardiovascular condition for drug efficacy | |
Castro-Poças et al. | Colon hemangiolymphangioma—a rare case of subepithelial polyp | |
KR102497196B1 (en) | A method to calculate a diagnostic score for a prostate cancer and use thereof | |
Li et al. | Pathology of cardiovascular interventions and surgery | |
Gonzalez | Intestinal Viability | |
WO2015171884A1 (en) | Endovascular cytology brush and method for use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: FOXHOLLOW TECHNOLOGIES, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SOITO, ANGELA;SIMPSON, JOHN B.;SIGNING DATES FROM 20060620 TO 20060621;REEL/FRAME:026608/0331 Owner name: EV3 INC., MINNESOTA Free format text: MERGER;ASSIGNOR:FOXHOLLOW TECHNOLOGIES, INC.;REEL/FRAME:026608/0353 Effective date: 20101220 Owner name: EV3 LLC, MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:EV3 INC.;REEL/FRAME:026610/0062 Effective date: 20101222 Owner name: TYCO HEALTHCARE GROUP LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EV3 LLC;REEL/FRAME:026608/0396 Effective date: 20101223 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |